A neuropharmacological study of 5-HT4 and 5-HT6 receptors and their relevance to Alzheimer’s disease

Sarawi, Wedad Shubily (2019). A neuropharmacological study of 5-HT4 and 5-HT6 receptors and their relevance to Alzheimer’s disease. University of Birmingham. Ph.D.

[img] Sarawi2019PhD.pdf
Text - Accepted Version
Restricted to Repository staff only until 1 September 2022.
Available under License All rights reserved.

Download (9MB) | Request a copy


This study aimed to determine the expression and potential interaction of 5-HT4 and 5-HT6 receptors in HEK293 and SH-SY5Y cell lines, to specify the role of N-linked glycosylation of the 5-HT4 receptor, and to assess the expression of these receptors at different stages of Alzheimer’s disease (AD). The results showed that both the cell lines natively express the 5-HT4 receptors but at a low level which prevented the detection of ERK1/2 phosphorylation. Contrastingly, overexpression of these receptors individually in HEK293 cells showed transient ERK1/2 phosphorylation, while concurrent overexpression of the receptors did not show augmentation effects in pERK1/2 level following 5-HT stimulation. The overexpressed 5-HT4 receptor showed the presence of N-glycosylation. Abrogation of asparagine at 180 position reduced the apparent weight and cell surface expression of 5-HT4 receptor.
Moreover, the 5-HT4 receptor was significantly downregulated in limbic and neocortical stages of AD relative to controls, whereas the 5-HT6 receptor expression was reduced in the neocortical stage relative to the limbic stage of AD. The variations in the receptor expression significantly correlated with the cognitive status of AD patients besides the phospho-tau. These data suggest that the early modulation of these receptors might improve AD and its associated symptoms.

Type of Work: Thesis (Doctorates > Ph.D.)
Award Type: Doctorates > Ph.D.
Licence: All rights reserved
College/Faculty: Colleges (2008 onwards) > College of Medical & Dental Sciences
School or Department: School of Pharmacy
Funders: Other
Other Funders: Royal Embassy of Saudi Arabia
Subjects: R Medicine > RM Therapeutics. Pharmacology
URI: http://etheses.bham.ac.uk/id/eprint/9344


Request a Correction Request a Correction
View Item View Item


Downloads per month over past year